FCG ADVISORS, LLC: BCSF position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of FCG ADVISORS, LLC on BCSF, newest first. How the timeline and the estimate are built.
FCG ADVISORS, LLC held 12,301 BCSF shares at 2020-09-30 per its 13F-HR filed 2020-11-13.
the latest 13F is the newest step
- period ended2020-09-3013F 12,301 sharesChange vs previous 13F +300 shares
0.03% of the 13F portfolio, value $125,000.
13F-HR 0000930413-20-002522 filed by FCG ADVISORS, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2020-06-3013F 12,001 sharesChange vs previous 13F -3,785 shares
0.03% of the 13F portfolio, value $133,000.
13F-HR 0000930413-20-001848 filed by FCG ADVISORS, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2020-03-3113F 15,786 sharesChange vs previous 13F +252 shares
0.04% of the 13F portfolio, value $146,000.
13F-HR 0000930413-20-001428 filed by FCG ADVISORS, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2019-12-3113F 15,534 sharesChange vs previous 13F +255 shares
0.09% of the 13F portfolio, value $307,000.
13F-HR 0000930413-20-000169 filed by FCG ADVISORS, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2019-09-3013F 15,279 sharesChange vs previous 13F +262 shares
0.09% of the 13F portfolio, value $290,000.
13F-HR 0000930413-19-002803 filed by FCG ADVISORS, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2019-06-3013F 15,017 sharesChange vs previous 13F not available
0.09% of the 13F portfolio, value $280,000.
13F-HR 0000930413-19-002263 filed by FCG ADVISORS, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).